Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An approach for preparing and responding to adverse events following immunization reported after hepatitis B vaccine birth dose administration.
Gidudu JF, Shaum A, Habersaat K, Wilhelm E, Woodring J, Mast E, Zuber P, Amarasinghe A, Nelson N, Kabore H, Abad N, Tohme RA. Gidudu JF, et al. Among authors: amarasinghe a. Vaccine. 2020 Nov 17;38(49):7728-7740. doi: 10.1016/j.vaccine.2019.07.041. Epub 2019 Jul 20. Vaccine. 2020. PMID: 31337590 Free PMC article. Review.
Template protocol for clinical trials investigating vaccines--focus on safety elements.
Bonhoeffer J, Imoukhuede EB, Aldrovandi G, Bachtiar NS, Chan ES, Chang S, Chen RT, Fernandopulle R, Goldenthal KL, Heffelfinger JD, Hossain S, Jevaji I, Khamesipour A, Kochhar S, Makhene M, Malkin E, Nalin D, Prevots R, Ramasamy R, Sellers S, Vekemans J, Walker KB, Wilson P, Wong V, Zaman K, Heininger U; Brighton Collaboration Clinical Trial Protocol Working Group. Bonhoeffer J, et al. Vaccine. 2013 Nov 12;31(47):5602-20. doi: 10.1016/j.vaccine.2013.02.041. Epub 2013 Mar 13. Vaccine. 2013. PMID: 23499603 Free PMC article.
Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization.
Amarasinghe A, Black S, Bonhoeffer J, Carvalho SM, Dodoo A, Eskola J, Larson H, Shin S, Olsson S, Balakrishnan MR, Bellah A, Lambach P, Maure C, Wood D, Zuber P, Akanmori B, Bravo P, Pombo M, Langar H, Pfeifer D, Guichard S, Diorditsa S, Hossain MS, Sato Y. Amarasinghe A, et al. Vaccine. 2013 Apr 18;31 Suppl 2:B108-14. doi: 10.1016/j.vaccine.2012.10.119. Vaccine. 2013. PMID: 23598471 Review.
An approach to death as an adverse event following immunization.
Gold MS, Balakrishnan MR, Amarasinghe A, MacDonald NE. Gold MS, et al. Among authors: amarasinghe a. Vaccine. 2016 Jan 4;34(2):212-217. doi: 10.1016/j.vaccine.2015.11.018. Epub 2015 Nov 19. Vaccine. 2016. PMID: 26608326 Review.
Strengthening of causality assessment of adverse events following immunization in the WHO South East Asia and Western Pacific regions: Lessons from the 2014 SEAR inter-country workshop.
MacDonald NE, Guichard S, Amarasinghe A, Balakrishnan MR; 2014 Inter-country SEAR Workshop Participants. MacDonald NE, et al. Among authors: amarasinghe a. Vaccine. 2015 Nov 27;33(48):6902-7. doi: 10.1016/j.vaccine.2015.01.033. Epub 2015 Jan 21. Vaccine. 2015. PMID: 25617790
Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards.
Beatty ME, Stone A, Fitzsimons DW, Hanna JN, Lam SK, Vong S, Guzman MG, Mendez-Galvan JF, Halstead SB, Letson GW, Kuritsky J, Mahoney R, Margolis HS; Asia-Pacific and Americas Dengue Prevention Boards Surveillance Working Group. Beatty ME, et al. PLoS Negl Trop Dis. 2010 Nov 16;4(11):e890. doi: 10.1371/journal.pntd.0000890. PLoS Negl Trop Dis. 2010. PMID: 21103381 Free PMC article.
101 results